| Literature DB >> 11445811 |
M Choi1, M P Massicotte, V Marzinotto, A K Chan, J L Holmes, M Andrew.
Abstract
We evaluated the efficacy and safety of alteplase to restore central venous line (CVL) patency in a consecutive cohort study. A uniform, weight-dependent protocol for alteplase administration was established prospectively. For children < or =10 kg, a dose of 0.5 mg was used; for children >10 kg, doses of 1 to 2 mg were used. The alteplase remained instilled for 1 to 4 hours or overnight. Retrospective data accrual found that 25 children received alteplase for a total of 34 courses; 29 (85%) of the 34 courses of alteplase completely restored CVL patency. Alteplase appears to be a safe and effective thrombolytic agent for CVL patency restoration in children.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11445811 DOI: 10.1067/mpd.2001.115019
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406